Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.

Zhang J, Wang WD, Geng QR, Wang L, Chen XQ, Liu CC, Lv Y.

PLoS One. 2014 Apr 10;9(4):e94637. doi: 10.1371/journal.pone.0094637. eCollection 2014.

2.

Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.

Wang H, Zhu JY, Liu CC, Zhu MY, Wang JH, Geng QR, Lu Y.

Med Oncol. 2015 Jan;32(1):370. doi: 10.1007/s12032-014-0370-4. Epub 2014 Nov 27.

PMID:
25428383
3.

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.

Wang H, Li P, Wang L, Xia Z, Huang H, Lu Y, Li Z.

Ann Hematol. 2015 Sep;94(9):1535-44. doi: 10.1007/s00277-015-2401-4. Epub 2015 May 21.

PMID:
25990795
4.

Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.

Niu SQ, Yang Y, Li YY, Wen G, Wang L, Li ZM, Wang HY, Zhang LL, Xia YF, Zhang YJ.

Chin J Cancer. 2016 Apr 4;35:34. doi: 10.1186/s40880-016-0096-0.

5.

Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.

Wang L, Liao DZ, Zhang J, Xia ZJ, Peng XW, Lu Y.

Med Oncol. 2013 Dec;30(4):723. doi: 10.1007/s12032-013-0723-4. Epub 2013 Sep 15.

PMID:
24037346
6.

Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.

Yamazaki E, Tomita N, Koyama S, Ogusa E, Ishii Y, Takahashi H, Miyashita K, Matsuura S, Tachibana T, Takasaki H, Takemura S, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y.

Med Oncol. 2014 Sep;31(9):149. doi: 10.1007/s12032-014-0149-7. Epub 2014 Aug 10.

PMID:
25108598
7.

Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.

Li ZM, Zhu YJ, Sun J, Xia Y, Huang JJ, Zou BY, Lin TY, Huang HQ, Jiang WQ.

Ann Hematol. 2012 Aug;91(8):1265-70. doi: 10.1007/s00277-012-1434-1. Epub 2012 Feb 29.

PMID:
22373550
8.

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.

Yoo C, Yoon DH, Jo JC, Yoon S, Kim S, Lee BJ, Huh J, Lee SW, Suh C.

Ann Hematol. 2014 Jun;93(6):995-1000. doi: 10.1007/s00277-014-2015-2. Epub 2014 Jan 19.

PMID:
24441948
9.

The role of Skp2 in extranodal NK/T-cell lymphoma.

Guo HQ, Pu XX, Guo CC, Rao HL, Li HR, Lin TY.

Chin J Cancer. 2010 May;29(5):567-71.

10.

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL.

Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28.

PMID:
21710236
11.

Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.

Li YJ, Li ZM, Xia Y, Huang JJ, Huang HQ, Xia ZJ, Lin TY, Li S, Cai XY, Wu-Xiao ZJ, Jiang WQ.

PLoS One. 2013 May 28;8(5):e64158. doi: 10.1371/journal.pone.0064158. Print 2013.

12.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
13.

Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.

Wu RY, Li YX, Wang WH, Jin J, Wang SL, Liu YP, Song YW, Fang H, Ren H, Liu QF, Wang ZY, Qi SN, Lu NN, Chen B, Zhang XM, Zhou LQ, Liu XF, Yu ZH.

Am J Clin Oncol. 2014 Feb;37(1):41-6. doi: 10.1097/COC.0b013e318261084b.

PMID:
22992625
14.

A novel prognostic model for extranodal natural killer/T-cell lymphoma.

Huang JJ, Zhu YJ, Xia Y, Zhao W, Lin TY, Jiang WQ, Huang HQ, Li ZM.

Med Oncol. 2012 Sep;29(3):2183-90. doi: 10.1007/s12032-011-0030-x. Epub 2011 Jul 23.

PMID:
21786011
15.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
16.

Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.

Wang L, Chi PD, Chen H, Xiang J, Xia ZJ, Zhang YJ.

Tumour Biol. 2014 Mar;35(3):2141-9.

PMID:
24122233
17.
18.

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.

Wang H, Wang L, Wuxiao Z, Huang H, Jiang W, Li Z, Lu Y, Xia Z.

Onco Targets Ther. 2015 Sep 14;8:2589-99. doi: 10.2147/OTT.S91077. eCollection 2015.

19.

Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.

Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM.

Ann Oncol. 2011 Jan;22(1):149-55. doi: 10.1093/annonc/mdq314. Epub 2010 Jul 1.

PMID:
20595450
20.

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

Chauchet A, Michallet AS, Berger F, Bedgedjian I, Deconinck E, Sebban C, Antal D, Orfeuvre H, Corront B, Petrella T, Hacini M, Bouteloup M, Salles G, Coiffier B.

J Hematol Oncol. 2012 Jun 8;5:27. doi: 10.1186/1756-8722-5-27.

Supplemental Content

Support Center